Gut microbiota as a potential key to modulating humoral immunogenicity of new platform COVID-19 vaccines

Signal Transduct Target Ther. 2023 May 3;8(1):178. doi: 10.1038/s41392-023-01445-0.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19 Vaccines / therapeutic use
  • COVID-19* / prevention & control
  • Gastrointestinal Microbiome*
  • Humans

Substances

  • COVID-19 Vaccines